Glycolysis is the process your cells use to break down glucose (sugar) into a simpler molecule called pyruvate, producing a small but fast supply of energy along the way. It happens in 10 sequential chemical reactions, takes place in the cytoplasm of virtually every cell in your body, and nets 2 ATP molecules (the cell’s energy currency) per glucose molecule processed. It is the oldest and most universal energy pathway in biology, shared by bacteria, plants, and animals alike.
How Glucose Gets Into Your Cells
Glucose is a large, polar molecule that can’t slip through a cell membrane on its own. Instead, it relies on a family of transport proteins embedded in the membrane. The two main types are sodium-glucose linked transporters (SGLTs), which actively pull glucose in alongside sodium ions, and facilitated diffusion glucose transporters (GLUTs), which shuttle glucose down its concentration gradient without requiring extra energy. Once glucose crosses the membrane, it’s immediately available to enter glycolysis.
The Investment Phase: Steps 1 Through 5
Glycolysis begins with an energy investment. Think of it like putting coins into a machine before it pays out. In the first five steps, the cell spends 2 ATP to prepare glucose for splitting.
In step 1, an enzyme called hexokinase attaches a phosphate group from ATP onto glucose, creating glucose-6-phosphate. This traps glucose inside the cell because the added phosphate group prevents it from slipping back out through membrane transporters. In step 2, the molecule is rearranged into a slightly different sugar form, fructose-6-phosphate. Step 3 is the most important regulatory point in the entire pathway: another ATP is spent to add a second phosphate group, producing fructose 1,6-bisphosphate. The enzyme responsible, phosphofructokinase-1 (PFK-1), controls how fast glycolysis runs, and is considered the rate-limiting step.
In step 4, the six-carbon sugar is split into two three-carbon molecules. One of these is glyceraldehyde 3-phosphate (G3P), which moves forward. The other is converted into G3P in step 5. From this point on, every remaining reaction happens twice per original glucose molecule.
The Payoff Phase: Steps 6 Through 10
Now the cell recoups its investment and then some. Because one glucose produced two G3P molecules, this entire phase runs in duplicate.
In step 6, each G3P picks up an inorganic phosphate and transfers electrons to a carrier molecule called NAD+, reducing it to NADH. NADH is valuable because it can later feed into the cell’s main energy-producing machinery if oxygen is available. Step 7 is the first ATP-generating reaction: a phosphate group is transferred directly from the intermediate onto ADP, creating ATP. This direct transfer is called substrate-level phosphorylation, and it doesn’t require oxygen.
Steps 8 and 9 rearrange the molecule and remove water, producing a high-energy compound called phosphoenolpyruvate (PEP). In step 10, the final step, PEP donates its phosphate group to ADP, generating a second ATP and leaving pyruvate as the end product. This reaction is also irreversible, meaning it only runs in one direction.
The Net Energy Yield
Adding it all up: the investment phase consumes 2 ATP, and the payoff phase produces 4 ATP (2 per each three-carbon molecule, times two). The net gain is 2 ATP per glucose. The pathway also generates 2 NADH molecules, which carry high-energy electrons that can produce additional ATP later if the cell has access to oxygen. On its own, glycolysis captures only a small fraction of the energy stored in glucose, but it produces that energy extremely quickly, which matters during sudden bursts of activity or when oxygen is scarce.
What Happens to Pyruvate
The fate of pyruvate depends on whether oxygen is available. When oxygen is plentiful, pyruvate enters the mitochondria and feeds into the citric acid cycle (also called the Krebs cycle), ultimately driving a much larger round of ATP production through oxidative phosphorylation. This aerobic route can extract roughly 30 to 32 additional ATP from the original glucose molecule.
When oxygen is limited, or in cells that lack mitochondria entirely (like red blood cells), pyruvate stays in the cytoplasm and is converted to lactate. This is anaerobic glycolysis. The conversion itself doesn’t produce extra ATP, but it recycles NADH back to NAD+, which is essential for keeping glycolysis running. Without that recycling, step 6 would stall and the whole pathway would grind to a halt. This is why your muscles produce lactate during intense exercise: oxygen delivery can’t keep up with demand, so anaerobic glycolysis picks up the slack.
How the Cell Controls the Speed of Glycolysis
PFK-1 is the master switch. When the cell already has plenty of ATP, ATP itself acts as a brake on PFK-1, slowing glycolysis down. Citrate, an intermediate from the citric acid cycle, also inhibits PFK-1, signaling that the cell’s energy-producing pathways are already well-fed. On the other hand, when ATP levels drop and ADP or AMP accumulates, PFK-1 speeds up to generate more energy.
A particularly powerful activator is fructose 2,6-bisphosphate, a signaling molecule (not a glycolytic intermediate) produced by a separate enzyme called PFK-2. In the liver, insulin activates PFK-2, which raises fructose 2,6-bisphosphate levels and revs up glycolysis after a meal. Glucagon, the hormone that rises during fasting, does the opposite: it inactivates PFK-2, lowering fructose 2,6-bisphosphate and putting the brakes on glycolysis so the liver can instead release glucose into the bloodstream.
The liver also regulates the last step of glycolysis through a specialized version of pyruvate kinase. This liver-type pyruvate kinase is activated by fructose 1,6-bisphosphate (a signal that glycolysis is actively running) and inhibited by ATP, fatty acids, and the amino acid alanine. Glucagon shuts it down during fasting; insulin turns it back on after eating. Muscle cells, by contrast, don’t respond to glucagon, so their glycolysis is governed mainly by local energy needs rather than hormonal signals from the pancreas.
Glycolysis in Cancer Cells
In the 1920s, German biochemist Otto Warburg noticed that tumor cells consumed far more glucose than the surrounding healthy tissue and converted most of it to lactate, even when oxygen was readily available. This phenomenon, now called the Warburg effect, is a hallmark of many cancers. Normal cells in the presence of oxygen would send pyruvate into the mitochondria for a much larger energy payoff, but cancer cells preferentially ferment glucose to lactate.
This seems wasteful, since aerobic glycolysis produces far less ATP per glucose molecule than full mitochondrial oxidation. But cancer cells compensate by dramatically increasing the rate of glucose uptake. Lactate production through glycolysis can occur 10 to 100 times faster than complete oxidation in the mitochondria, which may give rapidly dividing cells the speed and raw materials they need to build new cell components. This elevated glucose appetite is so reliable that it forms the basis of PET scans, which detect tumors by tracking where radioactive glucose accumulates in the body.

